The landscape of diabetes management is rapidly shifting, with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatid and Retatru tide represent important advancements; Tirzepatid already https://tirzepatide40mg853331.rimmablog.com/profile